ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

$14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists

October 24, 1996

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

Final Issue of the Year

December 13, 1985

NCAB Meeting Moved To October

July 20, 1979

Women With Early Breast Cancer Can Wait Up To 12-Weeks For Chemo, Study Finds

October 27, 2006